3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
4
Sarcoma
2
Triple Negative Breast Neoplasms
1
Sarcoma, Synovial
1
Pheochromocytoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Liposarcoma
1
Leiomyosarcoma
1
Inflammatory Breast Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Fibrosarcoma
1
Breast Neoplasms, Male
1
Interventions
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
pegfilgrastim
1
obinutuzumab
1
fludarabine phosphate
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Neuropsychological Tests
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Injections
1
Filgrastim
1
Contrast Media
1
Blood Specimen Collection
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, B-Cell
×
pegfilgrastim
×
Clear all
NCT01541072
2016-11-01
PALM2
Centre Leon Berard
Phase NA
Terminated
34 enrolled